Pruritus with pemphigoid autoantibodies is the tip of an iceberg.
View/ Open
File version
Accepted Manuscript (AM)
Author(s)
Byth, Lachlan A
Griffith University Author(s)
Year published
2019
Metadata
Show full item recordAbstract
To the Editor: I read with interest the recent study in which Lamberts et al1 describe the clinical features and disease course of a cohort of patients with nonbullous pemphigoid (NBP). Consistent with previous reports, they found that there is significant variability in the cutaneous manifestations of NBP, ranging from papules and nodules to urticarial plaques and eczematous lesions. They also confirmed the low rate of progression to blister formation, adding further weight to the view that NBP represents a distinct entity rather than a prodrome of bullous pemphigoid as was once thought.2To the Editor: I read with interest the recent study in which Lamberts et al1 describe the clinical features and disease course of a cohort of patients with nonbullous pemphigoid (NBP). Consistent with previous reports, they found that there is significant variability in the cutaneous manifestations of NBP, ranging from papules and nodules to urticarial plaques and eczematous lesions. They also confirmed the low rate of progression to blister formation, adding further weight to the view that NBP represents a distinct entity rather than a prodrome of bullous pemphigoid as was once thought.2
View less >
View less >
Journal Title
Journal of the American Academy of Dermatology
Volume
81
Issue
5
Copyright Statement
© 2019 The American Academy of Dermatology Inc. Published by Elsevier Ltd. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence, which permits unrestricted, non-commercial use, distribution and reproduction in any medium, providing that the work is properly cited.
Subject
Clinical sciences
autoantibodies
case finding
nonbullous pemphigoid
pruritus
Science & Technology